James “Jim” Sigg FDA\'s Deputy Commissioner for Operations and Chief Operating Officer | Official Website
James “Jim” Sigg FDA\'s Deputy Commissioner for Operations and Chief Operating Officer | Official Website
This is a 50% decrease from the number of companies cited in the previous month.
The citations in the county include:
- You did not establish and maintain procedures for testing, screening and determining the eligibility of HCT/P donors.
- HCT/P donors were not determined to be eligible based on the results of donor screening and testing.
- The eligibility of an HCT/P donor was not determined and documented by a responsible person, based on results of donor screening and donor testing.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
American Infertility of New York, P.C. | Biologics | 05/01/2024 | Testing, screening, donor eligibility procedures |
American Infertility of New York, P.C. | Biologics | 05/01/2024 | Determination based on screening and testing |
American Infertility of New York, P.C. | Biologics | 05/01/2024 | Responsible person to determine, document |
American Infertility of New York, P.C. | Biologics | 05/01/2024 | Name and personal info on accompanying records |
American Infertility of New York, P.C. | Biologics | 05/01/2024 | Accurate, indelible, legible |
American Infertility of New York, P.C. | Biologics | 05/01/2024 | Labeled re: biohazard, risks, test results |